Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou GS Biotech is a high-tech biotechnology company specializing in the research, development, and manufacturing of molecular diagnostic products. The company provides integrated solutions for clinical laboratories, including automated nucleic acid extraction systems, real-time PCR detection kits, and related reagents. Their product portfolio covers a wide range of infectious diseases, including respiratory pathogens like SARS-CoV-2, blood-borne viruses such as HBV and HCV, and sexually transmitted infections. GS Biotech is recognized for its expertise in magnetic bead-based extraction technology and has established a significant presence in both domestic and international diagnostic markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GS Biotech.